Kevin Hykes
President, CEO & DirectorMr. Kevin Hykes serves as Director of CVRx, Inc. since December 21, 2022 and serves as President and Chief Executive Officer since February 12, 2024. He served as President, Director & Chief Executive Officer at Augmedics LTD since March 2022 until 2024. He serves as a Director at Veran Medical Technologies, Inc. He served as an Operating Partner and Industry Advisor at Revival Healthcare Capital till January 2022. He served as an Industry Advisors at Revival Healthcare Capital. He served as President and Chief Executive Officer at Bardy Diagnostics, Inc. since 2020 until 2021 and served as its Director since February 2021 until 2021. He was an Advisory Board Member at Vensana Capital Management, LLC. He was Chief Executive Officer, President and Director at Relievant Medsystems, Inc. since September 19, 2017. He is responsible for transforming Relievant from a clinical stage entity to a commercial enterprise, developing the reimbursement strategy and team, enrolling and publishing three clinical trials and successfully launching Intracept therapy in the US market. Mr. Hykes served as an Operating Partner at Versant Venture Management, LLC. Mr. Hykes served as Chief Executive Officer of Metavention, Inc. and served as its Chairman. He serves as an independent Board Member at Metavention, Inc. He has continued his service as an Independent Director at Metavention. Prior to Bardy Diagnostics, he was an operating Partner at Revival Healthcare Capital. He served as Operating Partner at Versant Ventures. He served as Chief Commercial Officer at Visiogen, Inc. since August 2008. At Visiogen, he was responsible for developing the commercial launch strategy, building the commercial team and launching the Synchrony IOL in the European market. Mr. Hykes served as Chief Executive Officer and President at Cameron Health, Inc. since March 23, 2010 until 2012 and served as its Director. Previous to Visiogen, he served at Medtronic, where he held leadership positions in the CRM, Neurological, Heart Valve and Cardiac Surgery businesses in the US and Europe and led the creation of Medtronic’s Healthcare Systems group. Mr. Hykes served as an Independent Director of Hansen Medical, Inc. since July 28, 2009 until July 27, 2016. Mr. Hykes is an accomplished medical device industry executive with many years of experience successfully commercializing novel therapies on a global basis for both large and small organizations. He received his MBA, in Marketing and Finance from Northwestern University - Kellogg School of Management (1990-1992) and a BBA in Information Systems from the Wisconsin School of Business (1983-1987). He was Independent Director of Metavention, Inc. until July 2025.
Positions
- Company NameCVRx, Inc.Stock CodeCVRXPositionPresident, CEO & DirectorColleagues
- PBPhilip B. AdamsonChief Medical Officer
- JLJohn LandryChief Financial Officer
- BBBrent BinkowskiChief Operating Officer
- MKMatt KleinVice President, Legal & Compliance Officer
- MKMudit K. JainIndependent Director
- KGKirk G. NielsenIndependent Director
- MCMitchell C. HillIndependent Director
- JPJoseph P. SlatteryIndependent Lead Director
